Skip to content Skip to footer
36Kr Holdings Inc. to Report Third Quarter 2021 Financial Results on Thursday, December 9, 2021
BEIJING , Dec. 3, 2021 /PRNewswire/ -- 36Kr Holdings Inc. ("36Kr" or the "Company") (NASDAQ: KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants in China , today announced that it will report its third quarter 2021 unaudited financial results, on Thursday, December 9, 2021 , before the open of U.S.…
Onion Global Will Launch Eyelicious Cosmetic Contact Lens Brand
GUANGZHOU, China , Dec. 3, 2021 /PRNewswire/ -- Onion Global Limited ("Onion Global", the "Group" or the "Company") (NYSE: OG), a next-generation lifestyle brand platform that incubates, markets, and distributes the world's fresh, fashionable, and future brands to young people in China and across Asia , today announced that Xinyang Wujie or Sunwah Ocean…
OrigiMed announced its strategic partnership with Janssen to develop clinical innovative solutions driven by data science
SHANGHAI , Dec. 3, 2021 /PRNewswire/ -- OrigiMed Co., Ltd. ("OrigiMed") announced that the company has signed a memorandum of understanding (MoU) on strategic collaboration with Janssen (China) Research and Development Center of Johnson & Johnson (China) Investment Co., Ltd. ("Janssen"). Zili Li , M.D., M.P.H., Head of Asia Pacific R&D, Janssen Research & Development,…
Integrations and Automation that will Transform L&D
Key details of how Validity's partner – Qstream – has enhanced its integration capabilities to allow its microlearning platform to seamlessly connect with complementary systems: Can be integrated into organisations' learning management systems (LMS), human capital management, work management and communication and collaboration platforms to extend workplace learning capabilities and automate business processes across the…
GemForex announces partnership with global sporting icon, David Beckham
LIMASSOL, Cyprus , Dec. 3, 2021 /PRNewswire/ -- GemForex, Asia's leading online financial trading platform, continues to set new standards, following the announcement of a multi-year partnership with sporting icon, David Beckham . David will be helping to promote GemForex and its services across Asia . A spokesman for GemForex commented: "Both GemForex and…
RemeGen’s Telitacicept and Disitamab Vedotin Enter China’s National Reimbursement Drug List for SLE and Gastric Cancer Treatment
YANTAI, China , Dec. 3, 2021 /PRNewswire/ -- RemeGen Co., Ltd. (9995.HK), a commercial-ready biotechnology company, today announced that two of its innovative drugs, a dual-targeted TACI-Fc fusion protein, Telitacicept (RC18) for treating systemic lupus erythematosus (SLE) and a novel antibody-drug conjugate (ADC), Disitamab Vedotin (RC48) for treating locally advanced or metastatic gastric cancer, have…
Florasis releases the international version of theme song with popular singer Zhou Shen
A multi-language music interpretation of Chinese classical flavor by Zhou Shen More collaborations to bring the brand to the global audience Florasis's products are available in over 100 markets after launching global business HANGZHOU, China , Dec. 3 , 2021 /PRNewswire/ -- On December 2nd, 2021 , Chinese cosmetics brand…
Flood-drought cycles inspire launch of Argus Australian cattle price index
SYDNEY , Dec. 3, 2021 /PRNewswire/ -- Global energy and commodity price reporting agency Argus has expanded into livestock pricing with the launch of its weekly Australia northern feeder cattle index. The price has been developed in close consultation with industry participants and responds to growing demand for more transparency and risk management…
Innovent and Lilly Announce Successful Expansion of Sintilimab in China National Reimbursement Drug List to Include Three Additional First-Line Indications
SAN FRANCISCO, INDIANAPOLIS, and SUZHOU, China, Dec. 3, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, and Eli Lilly and Company ("Lilly") (NYSE: LLY), announce that the innovative PD-1 inhibitor sintilimab…
Ascletis Announces Inclusion in New Catalogue of China National Reimbursement Drug List (NRDL) of ASCLEVIR®/ GANOVO® Regimen, an All-oral Direct Anti-HCV Therapy
HANGZHOU , China and SHAOXING, China, Dec. 3, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that its all-oral direct anti-hepatitis C virus (HCV) ASCLEVIR® (Ravidasvir)/ GANOVO® (Danoprevir) regimen has been included in the Medicine Catalog for National Basic Medical Insurance, Work-Related Injury Insurance and Maternity Insurance (2021) (《国家基本医疗保险、工伤保险和生育保险药品目录(2021)年》) (the "National Reimbursement Drug List"…